Literature DB >> 2802745

[Immunoscintigraphy and intraoperative tumor search in ovarian cancer].

N Pateisky1, E Gitsch.   

Abstract

The diagnostic possibilities of immunoscintigraphy (IS) in ovarian cancer are discussed. Seventy-five patients were investigated by IS using the radioantibodies HMFG-2 (n = 63) or OC-125 (n = 12). The results showed a specificity of 75%, sensitivity of 87%, and accuracy of 84%. An intraoperatively usable gamma ray detection probe was developed in order to achieve better results than with conventional IS. Twelve patients were investigated using this probe. A future clinical value was indicated for intraoperative detection of lymphnode metastases and/or small tumor deposits.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802745     DOI: 10.1007/bf02417452

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  Radioimmunodetection in patients with suspected ovarian cancer.

Authors:  N Pateisky; K Philipp; W D Skodler; K Czerwenka; G Hamilton; J Burchell
Journal:  J Nucl Med       Date:  1985-12       Impact factor: 10.057

2.  Immunoscintigraphy of recurrences of gynecologic carcinomas.

Authors:  J F Chatal; P Fumoleau; J C Saccavini; P Thedrez; C Curtet; A Bianco-Arco; A Chetanneau; P Peltier; M Kremer; Y Guillard
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

3.  123I radioiodinated antibody imaging of occult ovarian cancer.

Authors:  A A Epenetos; J Shepherd; K E Britton; S Mather; J Taylor-Papadimitriou; M Granowska; H Durbin; C C Nimmon; L R Hawkins; J S Malpas
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

  3 in total
  2 in total

Review 1.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

2.  Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences.

Authors:  C Alexander; C E Villena-Heinsen; L Trampert; S Lung-Kurt; E Oberhausen; C M Kirsch; W Schmidt
Journal:  Eur J Nucl Med       Date:  1995-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.